Get the SPI Wire

ENDOVIA HEALTH SCIENCES, INC.

NYSE:EDVA
Annual Meeting

of Shareholders

MEETING DATE

11/20/2026
DEF 14A FILED
10/05/2026
PUBLISHED
10/05/2026 8:31 pm
TIME TO PUBLISH
10/07/2026
METHODOLOGY
approve
EXCHANGE NYSE:EDVA · CUSIP 13754P105 · CLASS common stock · CIK 0001553788

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

4
FOR
2
AGAINST
0
WITHHOLD
6
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Elect four directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified.
board
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The filing presents four nominees and does not disclose nominee-specific opposition or disqualifying concerns.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Ratify and approve the appointment of Rose, Snyder & Jacobs LLP as Company’s independent registered accounting firm for the fiscal year ending December 31, 2026.
auditor
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The Audit Committee discussed independence and determined non-audit services were compatible with maintaining independence.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Approve, on a non-binding advisory basis, the compensation paid to the Company’s named executive officers (the “Say on Pay Proposal”).
compensation
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The filing presents an advisory vote and does not disclose significant shareholder opposition or board-recognized compensation concerns.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
Approve, in accordance with the NYSE American Company Guide Section 711, the Amendment of the 2025 Plan to increase the number of shares authorized to be issued under the 2025 Plan, adopt an Automatic Ownership Maintenance feature, and enable the repricing of certain outstanding options.
compensation
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

The filing states the feature could cause ongoing substantial dilution and presents conflicts of interest for Covered Persons.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.
5
Approve and adopt in accordance with the NYSE American Company Guide Section 711, the grant of RSU Grants.
compensation
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

The filing states RSU Grants represent 20% of fully diluted shares outstanding, approximately 4,029,561 shares.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.
6
Approve an adjournment of the Annual Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if there are not sufficient votes at the time of the Annual Meeting to approve any of the proposals presented for a vote at the Annual Meeting.
other
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states adjournment may be used to permit further solicitation if votes are insufficient.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

e53f98c73aff8676aafba893cef383155902fefc128df8b2e0fb68b17026239b

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates